Sowell Financial Services’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-105
Closed 1542
2021
Q1
$0 Hold
105
﹤0.01% 3192
2020
Q4
$0 Sell
105
-25,200
-100% -$37.2K ﹤0.01% 2767
2020
Q3
$26K Sell
25,305
-12,000
-32% -$12.2K ﹤0.01% 1445
2020
Q2
$22K Hold
37,305
﹤0.01% 1427
2020
Q1
$18K Hold
37,305
﹤0.01% 1428
2019
Q4
$24K Hold
37,305
﹤0.01% 1375
2019
Q3
$36K Buy
+37,305
New +$44.9K ﹤0.01% 1092

Other funds holding IGC

Sowell Financial Services's IGC Position: Q2 2021 in Review

Sowell Financial Services sold out of IGC Pharma (IGC) in Q2 2021, closing a stake of 105 shares.

Sowell Financial Services first reported a position in IGC in Q3 2019 and held it in 7 quarters. The position peaked at $36K in Q3 2019. 29 funds tracked by Wall St. Rank hold IGC as of Q2 2021.

  • Sowell Financial Services reported no remaining IGC Pharma position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 105 IGC Pharma shares in Q2 2021.
  • Sowell Financial Services first reported a position in IGC Pharma in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's IGC Pharma position peaked at $36K in Q3 2019.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.